On Air Now

Current Show

The Huge Show   3:00 PM - 5:00 PM

We're talkin' sports on The Huge Show

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1450 AM Holland, MI

Weather

Current Conditions(Holland,MI 49422)

More Weather »
79° Feels Like: 82°
Wind: NW 17 mph Past 24 hrs - Precip: 0.12”
Current Radar for Zip

Tonight

Thunderstorms Early 66°

Tomorrow

Partly Cloudy 75°

Tues Night

Clear 62°

Cubist says urinary tract infection drug succeeds in study

(Reuters) - Cubist Pharmaceuticals Inc said its experimental treatment for a type of urinary tract infection showed it was as effective as an approved antibiotic.

The main goal of a late-stage trial was to show whether the treatment, a combination of ceftolozane and tazobactam, eradicated the infection and cured patients five to nine days after the last dose.

The most commonly reported adverse events of the treatment were headaches, constipation, hypertension, nausea and diarrhea.

Cubist said it was concluding another late-stage study with the drug in patients with complicated intra-abdominal infections, and expects to report results in late December.

Shares of the Massachusetts-based company closed at $65.50 on the Nasdaq on Friday.

(Reporting by Natalie Grover in Bangalore; Editing by Maju Samuel)

Comments